14 results
DEFM14A
SQZB
SQZ Biotechnologies Co
23 Jan 24
Proxy related to merger
4:31pm
, without limitation, the U.S. federal anti-kickback, fraud and abuse, false claims, consumer fraud, pricing reporting, and transparency laws and regulations … and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare
PREM14A
SQZB
SQZ Biotechnologies Co
12 Jan 24
Preliminary proxy related to merger
8:57am
, and transparency laws and regulations as well as similar state and foreign laws in the jurisdictions outside the U.S. Violation of any such laws or any other … and proposed federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription
10-K
2020 FY
SQZB
SQZ Biotechnologies Co
18 Mar 21
Annual report
6:31am
, data privacy and security, and transparency laws and regulations as well as similar state and foreign laws in the jurisdictions outside the U.S … inquiries and proposed federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost
424B4
SQZB
SQZ Biotechnologies Co
12 Feb 21
Prospectus supplement with pricing info
5:10pm
resulted in several U.S. Congressional inquiries and proposed and enacted federal legislation designed to, among other things, bring more transparency … cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. Legally
DRS
9gc5h41m8
1 Feb 21
Draft registration statement
12:00am
10-Q
jx4hwtr7hu
10 Dec 20
Quarterly report
4:46pm
424B4
u2prwil
30 Oct 20
Prospectus supplement with pricing info
4:54pm
S-1
58a0eztg
9 Oct 20
IPO registration
4:59pm
DRS/A
11or1 2t49p5mg
25 Sep 20
Draft registration statement (amended)
12:00am
DRS/A
e561znbect6h0
28 Aug 20
Draft registration statement (amended)
12:00am
DRS
cvycab m112rlj
21 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next